Peeken, J.C. ; Spraker, M.B.* ; Knebel, C.* ; Dapper, H.* ; Pfeiffer, D.* ; Devecka, M.* ; Thamer, A.* ; Shouman, M.A.* ; Ott, A.* ; von Eisenhart-Rothe, R.* ; Nüsslin, F.* ; Mayr, N.A.* ; Nyflot, M.J.* ; Combs, S.E.
Tumor grading of soft tissue sarcomas using MRI-based radiomics.
EBioMedicine 48, 332-340 (2019)
Background: Treatment decisions for multimodal therapy in soft tissue sarcoma (STS) patients greatly depend on the differentiation between low-grade and high-grade tumors. We developed MRI-based radiomics grading models for the differentiation between low-grade (G1) and high-grade (G2/G3) STS.Methods: The study was registered at ClinicalTrials.gov (number NCT03798795). Contrast-enhanced T1-weighted fat saturated (T1FSGd), fat-saturated T2-weighted (T2FS) MRI sequences, and tumor grading following the French Federation of Cancer Centers Sarcoma Group obtained from pre-therapeutic biopsies were gathered from two independent retrospective patient cohorts. Volumes of interest were manually segmented. After preprocessing, 1394 radiomics features were extracted from each sequence. Features unstable in 21 independent multiple-segmentations were excluded. Least absolute shrinkage and selection operator models were developed using nested cross-validation on a training patient cohort (122 patients). The influence of ComBatHarmonization was assessed for correction of batch effects.Findings: Three radiomic models based on T2FS, T1FSGd and a combined model achieved predictive performances with an area under the receiver operator characteristic curve (AUC) of 0.78, 0.69, and 0.76 on the independent validation set (103 patients), respectively. The T2FS-based model showed the best reproducibility. The radiomics model involving T1FSGd-based features achieved significant patient stratification. Combining the T2FS radiomic model into a nomogram with clinical staging improved prognostic performance and the clinical net benefit above clinical staging alone.Interpretation: MRI-based radiomics tumor grading models effectively classify low-grade and high-grade soft tissue sarcomas. (C) 2019 The Authors. Published by Elsevier B.V.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Soft Tissue Sarcoma ; Radiomics ; Tumor Grading ; Mri ; Risk Stratification ; Biomarker; Prediction; Model
Keywords plus
Language
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
2352-3964
e-ISSN
2352-3964
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 48,
Issue: ,
Pages: 332-340
Article Number: ,
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
Amsterdam [u.a.]
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Radiation Sciences
PSP Element(s)
G-501300-001
Grants
Copyright
Erfassungsdatum
2019-10-02